ARCHIVES

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 39 No. 26 | June 26, 2013

Download PDF Visit The Full Archive

Related Articles

Funds Earmarked From NCI Budget for Action Plan

October 24, 1996

BSA Approves 3 Concepts For Grants Worth $44 Million.

November 30, 2001

In Brief: Minority Based CCOP Workshop Planned; NCI Changes To 800-4-CANCER On Levamisole

August 4, 1989

Cancer Control, Smoking Programs Reorganized

December 7, 1990

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Clinton to Propose Increase for NIH & NCI Significantly Higher Than In Previous Years

January 9, 1998